Antibiotic Management for Pneumonia

Primary Considerations

The American Thoracic Society recommends distinguishing between community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) to guide antibiotic selection and coverage requirements 1, 2
Gram-positive cocci are most likely Staphylococcus aureus (including MRSA/MSSA) or Streptococcus pneumoniae 1, 2
Gram-positive bacilli may be Corynebacterium species, Listeria monocytogenes, or Bacillus species, but many are colonizers and require speciation 1
The presence of pleuritic chest pain, back pain, and buttock pain raises concern for septic emboli from S. aureus bacteremia or musculoskeletal involvement from systemic infection 1, 3

For hospitalized patients with CAP showing gram-positive organisms on culture, the American Journal of Respiratory and Critical Care Medicine recommends initiating combination therapy with a β-lactam PLUS a macrolide to cover both typical and atypical pathogens 4, 5
The preferred regimen includes cefepime 2 g IV q8h (or piperacillin-tazobactam 4.5 g IV q6h) PLUS azithromycin 500 mg IV daily 2, 3, 6
For patients with hospital-acquired pneumonia, empiric coverage must include MRSA and gram-negative organisms, with options including piperacillin-tazobactam, cefepime, or levofloxacin, and vancomycin or linezolid for MRSA coverage 2, 6, 7

Assessing for MRSA risk factors, including IV antibiotic use within 90 days, known MRSA colonization, and unit prevalence of MRSA among S. aureus isolates >20%, is crucial for guiding antibiotic selection 2, 6
Determining illness severity, including the need for ventilatory support and septic shock, helps guide the choice of antibiotic regimen 2, 9
Considering atypical coverage, even with gram-positive organisms visible, is essential, as atypical pathogens may coexist and are not visible on Gram stain 5, 4

Using aminoglycosides as sole antipseudomonal agent in HAP is not recommended 8, 9
Using β-lactam monotherapy if atypical pathogens are suspected in CAP is not recommended 4, 5
Assuming gram-positive bacilli are always pathogenic is incorrect, as many are colonizers, and awaiting speciation is necessary 1
Delaying MRSA coverage if risk factors are present increases mortality 2, 6

Once final culture identification and sensitivities return, tailoring the antibiotic regimen to the specific pathogen and its susceptibility pattern is essential 1, 3, 7, 8
If MSSA is confirmed, switching to oxacillin, nafcillin, or cefazolin is recommended 1, 3
If MRSA is confirmed, continuing vancomycin or linezolid is recommended 7, 8
If S. pneumoniae only is confirmed, narrowing to an appropriate β-lactam alone may be possible if no atypical symptoms are present 5